Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan dosing comparison in CHF
NCT00043771Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolvaptan in heart failure (HF), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started May 2002; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00043771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043771.